Therapeutics

Developing Next Generation Therapeutics for Healthy Life

Pipeline
Immunology
Project(Partners)
Target
Indication
Region
Discovery
Preclinical
IND
PH1
PH2
PH3
BLA Filing
view more

Batoclimab HBM9161(Hanall)

FcRn

ITP

GO

MG

NMOSD

Second Wave of Indications

Greater
China

Greater
China

Greater
China

Greater
China

Greater
China

view more

Tanfanercept HBM9036(Hanall)

TNFα

Dry Eye Disease

Greater
China

HBM9378

undisclosed

undisclosed

undisclosed

HBM9022(AbbVie; Utrecht University; Erasmus MC)

SARS-COV-2

COVID-19

Global license to AbbVie

Oncology
Project(Partners)
Target
Indication
Region
Discovery
Preclinical
IND
PH1
PH2
PH3
BLA Filing
view more

HBM4003

CTLA-4

Advanced Solid Tumors

Advanced Melanoma&Other Solid Tumors

Advanced NSCLC&Other Solid Tumors

Global

Global

Global

HBM9302(Ichnos)

HER2xCD3

Breast Cancer and Gastric Cancer

Greater China

HBM1007

CD73

Solid Tumors

Global

HBM1029

Claudin 18.2

Solid Tumors

Ex-Greater China

HBM7020

BCMAxCD3

Multiple Myeloma

Ex-Greater China

HBM7015

PD-L1xTGF-β

Solid Tumors

Ex-Greater China

HBM7008

TAA1x4-1BB

Solid Tumors

Global

HBM1022

CCR8

Solid Tumors

Global

  • HBM

  • Partner

  • Directly Initiate PH 3 Study

  • Registrational Clinical Trial

  • Monotherapy

  • + PD-(L )1

Target and other details not disclosed due to commercial sensitivity